These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 23956233)
41. Optic glioma in children: a retrospective analysis of 101 cases. Varan A; Batu A; Cila A; Soylemezoğlu F; Balcı S; Akalan N; Zorlu F; Akyüz C; Kutluk T; Büyükpamukçu M Am J Clin Oncol; 2013 Jun; 36(3):287-92. PubMed ID: 22547006 [TBL] [Abstract][Full Text] [Related]
42. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE; Nuding MA Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519 [TBL] [Abstract][Full Text] [Related]
43. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1. Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602 [TBL] [Abstract][Full Text] [Related]
44. The effect of chemotherapy on optic pathway gliomas and their sub-components: A volumetric MR analysis study. Shofty B; Mauda-Havakuk M; Weizman L; Constantini S; Ben-Bashat D; Dvir R; Pratt LT; Joskowicz L; Kesler A; Yalon M; Ravid L; Ben-Sira L Pediatr Blood Cancer; 2015 Aug; 62(8):1353-9. PubMed ID: 25858021 [TBL] [Abstract][Full Text] [Related]
45. Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas. Arnljots U; Nilsson M; Bolzani R; Benassi M; Sandvik U; Munoz DM; Blomgren K; Hellgren K PLoS One; 2024; 19(7):e0305548. PubMed ID: 38990917 [TBL] [Abstract][Full Text] [Related]
46. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence. Moreno L; Bautista F; Ashley S; Duncan C; Zacharoulis S Eur J Cancer; 2010 Aug; 46(12):2253-9. PubMed ID: 20400294 [TBL] [Abstract][Full Text] [Related]
47. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions? Aquilina K; Daniels DJ; Spoudeas H; Phipps K; Gan HW; Boop FA Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358 [TBL] [Abstract][Full Text] [Related]
48. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? Wolsey DH; Larson SA; Creel D; Hoffman R J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228 [TBL] [Abstract][Full Text] [Related]
49. Optic pathway glioma in children: 10 years of experience in a single institution. Doganis D; Pourtsidis A; Tsakiris K; Baka M; Kouri A; Bouhoutsou D; Varvoutsi M; Servitzoglou M; Dana H; Kosmidis H Pediatr Hematol Oncol; 2016 Mar; 33(2):102-8. PubMed ID: 27007263 [TBL] [Abstract][Full Text] [Related]
50. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Schefler AC; Cicciarelli N; Feuer W; Toledano S; Murray TG Ophthalmology; 2007 Jan; 114(1):162-9. PubMed ID: 17070578 [TBL] [Abstract][Full Text] [Related]
51. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications. Shamji MF; Benoit BG Neurosurg Focus; 2007; 23(5):E3. PubMed ID: 18004965 [TBL] [Abstract][Full Text] [Related]
52. Clustering of mutations in the 5' tertile of the NF1 gene in Slovakia patients with optic pathway glioma. Bolcekova A; Nemethova M; Zatkova A; Hlinkova K; Pozgayova S; Hlavata A; Kadasi L; Durovcikova D; Gerinec A; Husakova K; Pavlovicova Z; Holobrada M; Kovacs L; Ilencikova D Neoplasma; 2013; 60(6):655-65. PubMed ID: 23906300 [TBL] [Abstract][Full Text] [Related]
53. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105 [TBL] [Abstract][Full Text] [Related]
55. Serial MRIs provide novel insight into natural history of optic pathway gliomas in patients with neurofibromatosis 1. Sellmer L; Farschtschi S; Marangoni M; Heran MKS; Birch P; Wenzel R; Mautner VF; Friedman JM Orphanet J Rare Dis; 2018 Apr; 13(1):62. PubMed ID: 29685181 [TBL] [Abstract][Full Text] [Related]
56. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma. Boonzaier NR; Hales PW; D'Arco F; Walters BC; Kaur R; Mankad K; Cooper J; Liasis A; Smith V; O'Hare P; Hargrave D; Clark CA Neuroimage Clin; 2020; 28():102447. PubMed ID: 33038669 [TBL] [Abstract][Full Text] [Related]
57. Neurofibromatosis type 1 and optic pathway glioma. A long-term follow-up. Lama G; Esposito Salsano M; Grassia C; Calabrese E; Grassia MG; Bismuto R; Melone MA; Russo S; Scuotto A Minerva Pediatr; 2007 Feb; 59(1):13-21. PubMed ID: 17301720 [TBL] [Abstract][Full Text] [Related]
58. Visual Outcomes After Treatment for Sporadic Optic Pathway Gliomas in Pediatric Patients: A Systematic Review. Shlobin NA; Montgomery EY; Mohammad LM; Kandula V; Beestrum M; DeCuypere M; Lam SK World Neurosurg; 2022 Aug; 164():436-449.e2. PubMed ID: 35430402 [TBL] [Abstract][Full Text] [Related]
59. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH). Gnekow AK; Kortmann RD; Pietsch T; Emser A Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548 [TBL] [Abstract][Full Text] [Related]
60. Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab. Avery RA; Hwang EI; Jakacki RI; Packer RJ JAMA Ophthalmol; 2014 Jan; 132(1):111-4. PubMed ID: 24232489 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]